Innospec Inc. Profile Avatar - Palmy Investing

Innospec Inc.

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of special…

Chemicals - Specialty
US, Englewood [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 100% Best
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -8.70 47.38 51.89
Graham Fair Price 6.19 42.18 39.72
PEG -61.37 2.06 -5.34
Price/Book -0.53 2.66 2.67
Price/Cash Flow -20.62 47.51 59.86
Prices/Earnings -6.29 18.99 20.27
Price/Sales 1.50 6.29 6.19
Price/FCF -20.62 47.51 59.86
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin -1.10 0.31 0.31
Operating Margin 10.56 0.10 0.09
ROA 7.92 0.02 0.02
ROE 0.03 0.03 6.15
ROIC 0.03 0.03 -2.56
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.04 0.06 -44.28
Dividends QOQ 0.00 -1.00 -100.00
EBIT QOQ 0.09 0.12 26.67
EPS QOQ -0.04 0.09 142.54
FCF QOQ 0.24 0.29 23.76
Revenue QOQ 0.07 0.01 -83.14
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 79.67 79.50 -0.22
Days Sales Outstanding (DSO) 65.46 57.25 -12.53
Inventory Turnover 1.13 1.13 0.22
Debt/Capitalization 0.04 0.04 -6.28
Quick Ratio 1.52 1.61 6.29
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 46.13 47.55 3.07
Cash 8.19 10.85 32.46
Capex -0.85 -0.58 32.15
Free Cash Flow 2.06 2.66 29.16
Revenue 19.89 20.09 1.01
Naive Interpretation member
05 - Per Share Metrics · Best
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 2.38 2.50 4.94
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -2.83 -3.68 -29.91
Naive Interpretation Member
06 - Financial Health · Bad
End of IOSP's Analysis
CIK: 1054905 CUSIP: 45768S105 ISIN: US45768S1050 LEI: - UEI: -
Secondary Listings
IOSP has no secondary listings inside our databases.